N-(2-amino-4-fluorophenyl)-5-(1-phenylcyclopropanecarboxamido)picolinamide

Names and Identifiers

Canonical SMILES: Nc1cc(F)ccc1NC(=O)c1ccc(NC(=O)C2(c3ccccc3)CC2)cn1

Standard InChI: InChI=1S/C22H19FN4O2/c23-15-6-8-18(17(24)12-15)27-20(28)19-9-7-16(13-25-19)26-21(29)22(10-11-22)14-4-2-1-3-5-14/h1-9,12-13H,10-11,24H2,(H,26,29)(H,27,28)

Standard InChI Key: GOXJJMRPXJZYOP-UHFFFAOYSA-N

Molfile:

     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   15.3368  -23.4963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9323  -22.7864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5192  -23.4937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0688  -21.5565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0677  -22.3801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7798  -22.7891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4936  -22.3797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4908  -21.5529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7780  -21.1435    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.2011  -21.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9144  -21.5475    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.1980  -20.3162    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.6206  -21.1322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3324  -21.5456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0422  -21.1309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0396  -20.3087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3212  -19.9030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6143  -20.3159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9035  -19.9127    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.7493  -19.8965    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   16.3555  -22.7882    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.6440  -22.3790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6446  -21.5577    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.2244  -22.3779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2299  -21.5556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5192  -21.1424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8060  -21.5546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8080  -22.3801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5193  -22.7855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  1  3  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  8 10  1  0
 10 11  1  0
 10 12  2  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 18 19  1  0
 16 20  1  0
  5 21  1  0
 21 22  1  0
 22  2  1  0
 22 23  2  0
  2 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
M  END

Alternative Forms

Parent:

ALA4290246
---

Associated Targets(Human)

HDAC3 Tclin Histone deacetylase 3/Nuclear receptor corepressor 2 (HDAC3/NCoR2) (735 Activities)

Discover Target: HDAC3

Activity Type	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Molecule Features

Natural Product: No	Oral: No	Chemical Probe: No	Parenteral: No
Molecule Type: Small molecule	Topical: No	First In Class: No	Black Box: No
Chirality: No	Availability: No	Prodrug: No

Drug Indications

MESH ID	MESH Heading	EFO IDs	EFO Terms	Max Phase for Indication	References

Mechanisms of Action

Mechanism of Action	Action Type	target ID	Target Name	Target Type	Target Organism	Binding Site Name	References

Calculated Properties

Molecular Weight: 390.42	Molecular Weight (Monoisotopic): 390.1492	AlogP: 3.73	#Rotatable Bonds: 5
Polar Surface Area: 97.11	Molecular Species: NEUTRAL	HBA: 4	HBD: 3
#RO5 Violations: ┄	HBA (Lipinski): 6	HBD (Lipinski): 4	#RO5 Violations (Lipinski): ┄
CX Acidic pKa: 12.81	CX Basic pKa: 2.07	CX LogP: 3.25	CX LogD: 3.25
Aromatic Rings: 3	Heavy Atoms: 29	QED Weighted: 0.58	Np Likeness Score: -1.66

References

1. Adhikari N, Amin SA, Trivedi P, Jha T, Ghosh B.. (2018) HDAC3 is a potential validated target for cancer: An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approaches., 157 [PMID:30179749] [10.1016/j.ejmech.2018.08.081]

Source

Source(1):

Scientific Literature